FluoSphera uses a unique in vitro testing technology to offer advanced R&D services to companies willing to improve the efficacy and profitability of their drug development pipeline. Their patented technology allows the creation of in vitro human biosystems to reliably predict the effects of drugs on patients, and to reduce drug development failure.
“Prepare the comprehensive base for profitable communication”
6 weeksDuration from the idea to the |
4 meetingsCommunication with client is essential
|
2 roundsTwo feedback rounds on the
|
Thanks to the newly developed pitch deck and video, Fluosphera was selected for a MassChallenge US accelerator program. At the beginning 2023 Fluosphera secured its first seed round of 1 M USD.
Gregory SegalaCEO & Co-Founder |
"The video makes us more professional and credible." |